Viral MicroRNAs: Interfering the Interferon Signaling.


Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
2020
Historique:
received: 11 10 2019
accepted: 22 12 2019
pubmed: 12 1 2020
medline: 4 11 2020
entrez: 12 1 2020
Statut: ppublish

Résumé

Interferons are secreted cytokines with potent antiviral, antitumor and immunomodulatory functions. As the first line of defense against viruses, this pathway restricts virus infection and spread. On the contrary, viruses have evolved ingenious strategies to evade host immune responses including the interferon pathway. Multiple families of viruses, in particular, DNA viruses, encode microRNA (miR) that are small, non-protein coding, regulatory RNAs. Virus-derived miRNAs (v-miR) function by targeting host and virus-encoded transcripts and are critical in shaping host-pathogen interaction. The role of v-miRs in viral pathogenesis is emerging as demonstrated by their function in subverting host defense mechanisms and regulating fundamental biological processes such as cell survival, proliferation, modulation of viral life-cycle phase. In this review, we will discuss the role of v-miRs in the suppression of host genes involved in the viral nucleic acid detection, JAK-STAT pathway, and cytokine-mediated antiviral gene activation to favor viral replication and persistence. This information has yielded new insights into our understanding of how v-miRs promote viral evasion of host immunity and likely provide novel antiviral therapeutic targets.

Identifiants

pubmed: 31924149
pii: CPD-EPUB-103587
doi: 10.2174/1381612826666200109181238
pmc: PMC7476571
mid: NIHMS1607081
doi:

Substances chimiques

MicroRNAs 0
RNA, Viral 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

446-454

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE027980
Pays : United States
Organisme : NIDCR NIH HHS
ID : R03 DE027147
Pays : United States
Organisme : NIDCR NIH HHS
ID : R21 DE026259
Pays : United States

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Références

Biochim Biophys Acta Gene Regul Mech. 2018 May;1861(5):497-508
pubmed: 29550353
Front Immunol. 2018 Mar 06;9:433
pubmed: 29559974
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7836-9
pubmed: 1502203
Mol Diagn Ther. 2017 Feb;21(1):45-57
pubmed: 27682074
PLoS Pathog. 2012 Jan;8(1):e1002484
pubmed: 22291592
Retrovirology. 2008 Dec 23;5:117
pubmed: 19102781
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8555-9
pubmed: 2236065
Oncogene. 2009 Nov 5;28(44):3903-14
pubmed: 19718044
Genes Dev. 1998 Jul 1;12(13):2061-72
pubmed: 9649509
Rev Immunogenet. 2000;2(3):374-86
pubmed: 11256746
Science. 1992 Aug 7;257(5071):809-13
pubmed: 1496401
Methods Mol Biol. 2011;721:43-66
pubmed: 21431678
Viruses. 2013 Jun 21;5(6):1587-606
pubmed: 23793113
J Biol Chem. 2002 Jun 21;277(25):22304-13
pubmed: 11940575
Am J Pathol. 2014 Apr;184(4):1185-97
pubmed: 24655378
Science. 2004 Apr 30;304(5671):734-6
pubmed: 15118162
J Endod. 2017 Jan;43(1):84-89
pubmed: 27939730
Cell Res. 2011 May;21(5):793-806
pubmed: 21221132
J Autoimmun. 2017 Sep;83:1-11
pubmed: 28330758
Biochem Pharmacol. 2006 Nov 30;72(11):1538-46
pubmed: 16750817
J Biol Chem. 2005 Jun 24;280(25):24153-8
pubmed: 15845545
Science. 1995 Mar 3;267(5202):1347-9
pubmed: 7871432
Cytokine Growth Factor Rev. 2015 Apr;26(2):183-94
pubmed: 25466647
Rev Med Virol. 2020 Jan;30(1):e2081
pubmed: 31432608
J Virol. 2013 May;87(9):5219-28
pubmed: 23449802
Nat Rev Immunol. 2002 Sep;2(9):675-87
pubmed: 12209136
Nature. 2012 Feb 15;482(7385):331-8
pubmed: 22337052
J Virol. 2014 Feb;88(3):1617-35
pubmed: 24257599
J Interferon Res. 1984 Spring;4(2):275-82
pubmed: 6086780
Immunol Rev. 2004 Dec;202:8-32
pubmed: 15546383
Nat Immunol. 2015 Aug;16(8):802-9
pubmed: 26194286
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16164-9
pubmed: 17911266
Int J Biol Sci. 2009;5(2):97-117
pubmed: 19173032
Mol Cell Biol. 2007 Apr;27(8):2910-8
pubmed: 17296724
Front Immunol. 2017 Mar 02;8:209
pubmed: 28303139
J Innate Immun. 2017;9(6):574-586
pubmed: 28877527
Nat Med. 2007 Oct;13(10):1241-7
pubmed: 17906637
EMBO J. 1991 Apr;10(4):927-32
pubmed: 1901265
Science. 2005 Sep 2;309(5740):1577-81
pubmed: 16141076
PLoS Pathog. 2013;9(12):e1003818
pubmed: 24367263
Nat Rev Immunol. 2019 Jan;19(1):31-44
pubmed: 30301972
Lancet. 2001 Jun 2;357(9270):1777-89
pubmed: 11403834
Science. 1996 Dec 6;274(5293):1739-44
pubmed: 8939871
Viruses. 2018 Dec 14;10(12):
pubmed: 30558110
Nucleic Acids Res. 2006;34(21):6233-46
pubmed: 17090584
J Biol Chem. 2002 Aug 16;277(33):30072-8
pubmed: 12048190
Nat Rev Mol Cell Biol. 2002 Sep;3(9):651-62
pubmed: 12209125
J Immunol. 2017 May 15;198(10):4062-4073
pubmed: 28416598
Neoplasia. 2009 Nov;11(11):1174-84
pubmed: 19881953
J Biol Chem. 2003 Jul 25;278(30):28193-200
pubmed: 12740372
Curr Opin Struct Biol. 2001 Dec;11(6):703-15
pubmed: 11751052
Mol Cell Biochem. 2012 Jun;365(1-2):203-10
pubmed: 22350759
Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1172-6
pubmed: 1847510
Biochimie. 2015 Oct;117:119-28
pubmed: 25868999
J Virol. 2006 Jun;80(11):5156-67
pubmed: 16698996
Annu Rev Biochem. 2010;79:351-79
pubmed: 20533884
J Clin Periodontol. 2019 Jan;46(1):51-61
pubmed: 30499589
Dev Cell. 2003 Feb;4(2):205-17
pubmed: 12586064
J Biol Chem. 2017 Jun 16;292(24):10262-10274
pubmed: 28455446
J Virol. 2014 May;88(9):4908-20
pubmed: 24554650
J Extracell Vesicles. 2014 Mar 25;3:
pubmed: 24678387
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E894-901
pubmed: 26831114
Annu Rev Med. 2015;66:311-28
pubmed: 25587654
J Virol. 2005 Jun;79(12):7371-9
pubmed: 15919892
J Cancer. 2018 Jul 30;9(16):2852-2864
pubmed: 30123354
Front Immunol. 2018 Sep 27;9:2099
pubmed: 30319604
Biochem Biophys Res Commun. 1997 Dec 8;241(1):92-7
pubmed: 9405239
Int Anesthesiol Clin. 2007 Spring;45(2):27-37
pubmed: 17426506
EMBO J. 2012 May 2;31(9):2207-21
pubmed: 22473208
Curr Top Microbiol Immunol. 2007;316:71-95
pubmed: 17969444
EMBO J. 2002 Apr 2;21(7):1754-63
pubmed: 11927559
J Virol. 2009 Oct;83(19):9618-29
pubmed: 19640997
J Virol. 2008 Feb;82(4):1946-58
pubmed: 18057241
PLoS Pathog. 2017 Aug 24;13(8):e1006524
pubmed: 28837697
EMBO J. 2003 Feb 3;22(3):537-47
pubmed: 12554654
J Interferon Cytokine Res. 1997 Mar;17(3):121-34
pubmed: 9085936
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Circulation. 2011 Jul 12;124(2):175-84
pubmed: 21690488
Science. 1992 Dec 11;258(5089):1808-12
pubmed: 1281555
Rev Med Virol. 2007 Jan-Feb;17(1):45-57
pubmed: 17146841
Immunol Lett. 2015 Feb;163(2):151-6
pubmed: 25530545
Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67
pubmed: 13465720
Cell Mol Life Sci. 2016 Oct;73(19):3733-44
pubmed: 27094387
PLoS One. 2013 Sep 04;8(9):e74472
pubmed: 24023945
J Virol. 2012 Apr;86(8):4380-93
pubmed: 22318153
PLoS One. 2011;6(11):e27271
pubmed: 22102884

Auteurs

Imran Ahmad (I)

Mucosal Immunology Lab, College of Dentistry, University of Illinois at Chicago, Chicago, Illinois, IL 60612, United States.

Araceli Valverde (A)

Mucosal Immunology Lab, College of Dentistry, University of Illinois at Chicago, Chicago, Illinois, IL 60612, United States.

Hasan Siddiqui (H)

Mucosal Immunology Lab, College of Dentistry, University of Illinois at Chicago, Chicago, Illinois, IL 60612, United States.

Samantha Schaller (S)

Mucosal Immunology Lab, College of Dentistry, University of Illinois at Chicago, Chicago, Illinois, IL 60612, United States.

Afsar R Naqvi (AR)

Mucosal Immunology Lab, College of Dentistry, University of Illinois at Chicago, Chicago, Illinois, IL 60612, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH